Close Menu

It's been four years and the California Institute of Regenerative Medicine is barely off the ground. In June, its newest director, Alan Trounson, allotted $23 million in funding for research on human embryonic stem cells as well as iPS adult stem cell lines, according to the Wall Street Journal. Next, Trounson will fund teams to focus on specific diseases and he hopes to take those therapies to clinical trials within five years.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.